EUVIMEDEUVIMED entdecken
Crossref

Xiaoqinglong Decoction Attenuates Inflammatory Response and Mitochondrial Injury by Regulating the MyD88/NF-κB Pathway Dependent of TLR4 in Allergic Rhinitis

Yongjun Wu, Qi Yang, Yao Sun, Jingjuan An, Lirong Wang, Caiming Zhang, Youpeng Fei, Kunmin Wu, Xiaofu Zhai, Yongjun Wu

International Archives of Allergy and Immunology · 26.02.2025 · 186 (10) · 927-940

DOI: 10.1159/000544768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, online erschienen am 26.02.2025. Verfasst von Yongjun Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Toll-Like Receptor 4, Rhinitis, Allergic, NF-kappa B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allergic rhinitis (AR) is a systemic immune inflammatory response disease of the nasal mucosa. Current treatment strategies for AR are limited, owing to a lack of safety and the inability to cure the condition completely. Xiaoqinglong decoction (XQLD), a classical chinese medicine prescription, is widely used to treat AR with a good curative effect. Although the clinical effect of XQLD has been demonstrated, the molecular mechanisms of therapeutical effect were unclear. Hence, the study aimed to investigate effects of XQLD on inflammation and the underlying mechanism for AR management.

Methods

Ovalbumin sensitization was used to induce AR in rats, and the nasal symptoms were evaluated. Hematoxylin-eosin staining was performed to detect epithelial cells of the nasal mucosa. Inflammatory factors were estimated to evaluate the anti-inflammatory effect of XQLD. Toll-like receptor 4 (TLR4) activity and myeloid differentiation factor 88 (MyD88)/nuclear factor kappa B (NF-κB) pathway were determined via immunofluorescence and Western blotting. Mitochondrial morphology and damage-related factors were assessed to determine the protective effect of XQLD.

Results

The results showed that XQLD supplementation inhibited AR-induced release of inflammatory factors, relieved nasal symptoms, and improved mitochondrial functions. Moreover, it suppressed TLR4 and MyD88 expression as well as NF-κB p65 acetylation following AR.

Conclusion

Inflammatory response and mitochondrial injury and the related MyD88/NF-κB signaling pathway play crucial roles in AR. XQLD supplementation inhibits AR-induced inflammation and mitochondrial injury by regulating TLR4 expression and TLR4-mediated MyD88/NF-κB pathway activation, thereby facilitating the therapeutic effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Differentiation Factor 88Toll-Like Receptor 4Rhinitis, AllergicNF-kappa BDrugs, Chinese HerbalMitochondriaAnti-Inflammatory AgentsAnimalsSignal TransductionRatsMaleNasal MucosaDisease Models, AnimalRats, Sprague-DawleyInflammationHumans

Stichwörter der Autor:innen

Allergic rhinitisMitochondrial injuryMyD88NF-κBTLR4Xiaoqinglong decoction

Substanzen

Myeloid Differentiation Factor 88Toll-Like Receptor 4NF-kappa BDrugs, Chinese HerbalTlr4 protein, ratMyd88 protein, ratAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Otolaryngology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Testing, Jiangsu Quality Inspection and Testing Center for Animal Products, Nanjing, China.
  • Department of Neurosurgery, Lianshui People's Hosptial of Kangda College Affiliated to Nanjing Medical University, Huaian, China.
  • Department of Otolaryngology, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, China.

Zitieren

APA

Wu, Y., Yang, Q., Sun, Y., An, J., Wang, L., Zhang, C., Fei, Y., Wu, K., Zhai, X., & Wu, Y. (2025). Xiaoqinglong Decoction Attenuates Inflammatory Response and Mitochondrial Injury by Regulating the MyD88/NF-κB Pathway Dependent of TLR4 in Allergic Rhinitis. International Archives of Allergy and Immunology, 186(10), 927-940. https://doi.org/10.1159/000544768

Vancouver

Wu Y, Yang Q, Sun Y, An J, Wang L, Zhang C, et al. Xiaoqinglong Decoction Attenuates Inflammatory Response and Mitochondrial Injury by Regulating the MyD88/NF-κB Pathway Dependent of TLR4 in Allergic Rhinitis. International Archives of Allergy and Immunology. 2025;186(10):927-940. doi:10.1159/000544768

BibTeX
@article{Wu2025,
  author = {Wu, Yongjun and Yang, Qi and Sun, Yao and An, Jingjuan and Wang, Lirong and Zhang, Caiming and Fei, Youpeng and Wu, Kunmin and Zhai, Xiaofu and Wu, Yongjun},
  title = {Xiaoqinglong Decoction Attenuates Inflammatory Response and Mitochondrial Injury by Regulating the MyD88/NF-κB Pathway Dependent of TLR4 in Allergic Rhinitis},
  journal = {International Archives of Allergy and Immunology},
  year = {2025},
  volume = {186},
  number = {10},
  pages = {927--940},
  doi = {10.1159/000544768}
}
Kostenlos starten →